GE

273.63

-0.32%↓

RTX

159.9

+0.15%↑

CAT

433.04

+0.46%↑

BA

235.71

+0.5%↑

GEV.US

622.92

-0.49%↓

GE

273.63

-0.32%↓

RTX

159.9

+0.15%↑

CAT

433.04

+0.46%↑

BA

235.71

+0.5%↑

GEV.US

622.92

-0.49%↓

GE

273.63

-0.32%↓

RTX

159.9

+0.15%↑

CAT

433.04

+0.46%↑

BA

235.71

+0.5%↑

GEV.US

622.92

-0.49%↓

GE

273.63

-0.32%↓

RTX

159.9

+0.15%↑

CAT

433.04

+0.46%↑

BA

235.71

+0.5%↑

GEV.US

622.92

-0.49%↓

GE

273.63

-0.32%↓

RTX

159.9

+0.15%↑

CAT

433.04

+0.46%↑

BA

235.71

+0.5%↑

GEV.US

622.92

-0.49%↓

Search

India Globalization Capital Inc

Cerrado

0.44 15.79

Resumen

Variación precio

24h

Actual

Mínimo

0.37

Máximo

0.48

Métricas clave

By Trading Economics

Ingresos

-402K

-1.6M

Ventas

-2K

328K

BPA

-0.015

Margen de beneficio

-487.5

Empleados

70

EBITDA

-506K

-1.8M

Dividendos

By Dow Jones

Próximas Ganancias

10 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

6.5M

35M

Apertura anterior

-15.35

Cierre anterior

0.44

India Globalization Capital Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

3 sept 2024, 04:00 UTC

Principales Noticias

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

Comparación entre iguales

Cambio de precio

India Globalization Capital Inc Esperado

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.